Guideline
EAS consensus panel: Lp(a) as a cardiovascular risk factor, current status (2010)
Status Historical (replaced by the 2022 statement)
Nordestgaard, Chapman, Ray and colleagues, European Heart Journal 2010: the document that set the 50 mg/dL (80th percentile) desirable level and the first testing recommendations, in the niacin and apheresis era.
Page updated 17 August 2026.